Site Map

ABOUT US
Overview
Management
Board
Scientific Advisors
Partnerships

TECHNOLOGY
INxin™ Platform
PORxin™ Platform
Scientific Conferences
Publications

PRODUCTS
Pipeline
PRX321

PRX302

Clinical Trials
Links

INVESTORS
News
Downloads
Stock
Events Calendar
FAQ

NEWS & MEDIA
News
Media Coverage
Media Kit
Events Calendar

CAREERS
Mission
About Vancouver
Current Opportunities

CONTACT US

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39